Treating Smokers With Mental Illness

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

May 4, 2020

Study Completion Date

May 4, 2020

Conditions
Smoking CessationCigarette SmokingSchizophreniaPsychotic DisordersMajor Depressive DisorderBipolar Disorder IBipolar II DisorderMental Illness
Interventions
DRUG

Nicotine patch

Nicotine patch (dose based on number of cigarettes per day) (4-week, 8-week, or 12-week supply) depending on participant preference and how much they are smoking based on FDA guidelines for use

DRUG

Nicotine lozenge

Nicotine lozenge (2 or 4 mg if less or greater than 30 minutes to first cigarette in the morning respectively) (4-week, 8-week, or 12-week supply) depending on participant preference and how much they are smoking based on FDA guidelines for use

BEHAVIORAL

Therapy

In-person meeting at baseline, 6 phone counseling sessions with participants over 8 weeks after initial in-person meeting, possible additional phone counseling (3 phone calls) from 8 weeks to 6 months after initial in-person meeting, and possible text messages when agreed to by participants during the 8 week to 6 month phase

OTHER

Information

Information about smoking and mental illness and referrals to both the QUITPLAN helpline and additional resources in the community

Trial Locations (1)

55455

University of Minnesota, Minneapolis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hennepin County Medical Center, Minneapolis

OTHER

collaborator

Brown University

OTHER

lead

University of Minnesota

OTHER